☰

Hongjuan Zhao, Ph.D. - Publications

Affiliations: 
Washington University, Saint Louis, St. Louis, MO 
Area:
Synapse Development, C. elegans, zebrafish
Tree Info Grants Similar researchers PubMed Report error

43 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Xiao Y, Thakkar KN, Zhao H, Broughton J, Li Y, Seoane JA, Diep AN, Metzner TJ, von Eyben R, Dill DL, Brooks JD, Curtis C, Leppert JT, Ye J, Peehl DM, et al. The mA RNA demethylase FTO is a HIF-independent synthetic lethal partner with the VHL tumor suppressor. Proceedings of the National Academy of Sciences of the United States of America. PMID 32817424 DOI: 10.1073/Pnas.2000516117  0.36
2019 Vijayalakshmi K, Shankar V, Bain RM, Nolley R, Sonn GA, Kao CS, Zhao H, Tibshirani R, Zare RN, Brooks JD. Identification of Diagnostic Metabolic Signatures in Clear Cell Renal Cell Carcinoma Using Mass Spectrometry Imaging. International Journal of Cancer. PMID 31863456 DOI: 10.1002/Ijc.32843  0.307
2019 Xiao Y, Zhao H, Tian L, Nolley R, Diep AN, Ernst A, Fuh KC, Miao YR, von Eyben R, Leppert JT, Brooks JD, Peehl DM, Giaccia AJ, Rankin EB. S100A10 is a critical mediator of GAS6/AXL-induced angiogenesis in renal cell carcinoma. Cancer Research. PMID 31585940 DOI: 10.1158/0008-5472.Can-19-1366  0.337
2017 Zhao H, Ning S, Nolley R, Scicinski J, Oronsky B, Knox SJ, Peehl DM. The immunomodulatory anticancer agent, RRx-001, induces an interferon response through epigenetic induction of viral mimicry. Clinical Epigenetics. 9: 4. PMID 28149332 DOI: 10.1186/S13148-017-0312-Z  0.314
2017 Zhao H, Ning S, Nolley R, Scicinski J, Oronsky B, Knox SJ, Peehl DM. Abstract 4358: The immunomodulatory anticancer agent RRx-001 induces a vaccine-like interferon response through epigenetic induction of viral mimicry Cancer Research. 77: 4358-4358. DOI: 10.1158/1538-7445.Am2017-4358  0.321
2016 Oronsky B, Paulmurugan R, Foygel K, Scicinski J, Knox SJ, Peehl D, Zhao H, Ning S, Cabrales P, Summers TA, Reid TR, Fitch WL, Kim MM, Trepel JB, Lee MJ, et al. RRx-001: A Systemically Non-Toxic M2-to-M1 Macrophage Stimulating and Prosensitizing Agent In Phase II Clinical Trials. Expert Opinion On Investigational Drugs. PMID 27935336 DOI: 10.1080/13543784.2017.1268600  0.313
2016 Zhao H, Nolley R, Chan AM, Rankin EB, Peehl DM. Cabozantinib inhibits tumor growth and metastasis of a patient-derived xenograft model of papillary renal cell carcinoma with MET mutation. Cancer Biology & Therapy. 0. PMID 27715452 DOI: 10.1080/15384047.2016.1219816  0.319
2016 Valta MP, Zhao H, Saar M, Tuomela J, Nolley R, Linxweiler J, Sandholm J, Lehtimäki J, Härkönen P, Coleman I, Nelson PS, Corey E, Peehl DM. Spheroid culture of LuCaP 136 patient-derived xenograft enables versatile preclinical models of prostate cancer. Clinical & Experimental Metastasis. PMID 26873136 DOI: 10.1007/S10585-016-9781-2  0.338
2016 Zhao H, Leppert JT, Peehl DM. A Protective Role for Androgen Receptor in Clear Cell Renal Cell Carcinoma Based on Mining TCGA Data. Plos One. 11: e0146505. PMID 26814892 DOI: 10.1371/Journal.Pone.0146505  0.328
2015 Zhao H, Ning S, Scicinski J, Oronsky B, Knox SJ, Peehl DM. Epigenetic effects of RRx-001: a possible unifying mechanism of anticancer activity. Oncotarget. PMID 26657731 DOI: 10.18632/Oncotarget.6526  0.328
2015 Lai CY, Wen LL, Zhang Y, Luo SS, Wang QY, Luo YH, Chen R, Yang X, Rittmann BE, Zhao HP. Autotrophic antimonate bio-reduction using hydrogen as the electron donor. Water Research. 88: 467-474. PMID 26519630 DOI: 10.1016/J.Watres.2015.10.042  0.404
2015 Zhao H, Ning S, Scicinski J, Oronsky B, Knox S, Peehl DM. Abstract 3515: RRx-001: A double action systemically non-toxic epigenetic agent for cancer therapy Cancer Research. 75: 3515-3515. DOI: 10.1158/1538-7445.Am2015-3515  0.327
2014 Saar M, Zhao H, Nolley R, Young SR, Coleman I, Nelson PS, Vessella RL, Peehl DM. Spheroid culture of LuCaP 147 as an authentic preclinical model of prostate cancer subtype with SPOP mutation and hypermutator phenotype. Cancer Letters. 351: 272-80. PMID 24998678 DOI: 10.1016/J.Canlet.2014.06.014  0.362
2014 Ingels A, Zhao H, Thong AE, Saar M, Valta MP, Nolley R, Santos J, Peehl DM. Preclinical trial of a new dual mTOR inhibitor, MLN0128, using renal cell carcinoma tumorgrafts. International Journal of Cancer. Journal International Du Cancer. 134: 2322-9. PMID 24243565 DOI: 10.1002/Ijc.28579  0.302
2013 Zhao H, Thong A, Nolley R, Reese SW, Santos J, Ingels A, Peehl DM. Patient-derived tissue slice grafts accurately depict response of high-risk primary prostate cancer to androgen deprivation therapy. Journal of Translational Medicine. 11: 199. PMID 23985008 DOI: 10.1186/1479-5876-11-199  0.307
2013 Zhao H, Sun N, Young SR, Nolley R, Santos J, Wu JC, Peehl DM. Induced pluripotency of human prostatic epithelial cells. Plos One. 8: e64503. PMID 23717621 DOI: 10.1371/Journal.Pone.0064503  0.333
2013 Valta M, Zhao H, Ingels A, Thong A, Nolley R, Saar M, Peehl D. Abstract B9: Mouse model of primary human renal cell carcinoma metastasis to bone Cancer Research. 73. DOI: 10.1158/1538-7445.Tim2013-B9  0.311
2013 Zhao H, Thong A, Nolley R, Reese S, Santos J, Ingels A, Peehl D. Abstract B32: Patient-derived tissue slice grafts of high-risk primary prostate cancer: An authentic preclinical model for synthetic lethality-based therapy Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Pms-B32  0.361
2012 Tian J, Zhao H, Nolley R, Reese SW, Young SR, Li X, Peehl DM, Knox SJ. Darinaparsin: solid tumor hypoxic cytotoxin and radiosensitizer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 3366-76. PMID 22535156 DOI: 10.1158/1078-0432.Ccr-11-3179  0.312
2012 Zhao H, Thong A, Nolley R, Reese S, Santos J, Peehl D. Abstract A3: A tumorgraft model of castration-resistant primary prostate cancer Cancer Research. 72. DOI: 10.1158/1538-7445.Prca2012-A3  0.369
2011 Tian J, Zhao H, Nolley R, Reese S, Li X, Peehl D, Knox S. Abstract C129: Darinaparsin sensitizes solid tumors but not normal tissues to radiation. Molecular Cancer Therapeutics. 10. DOI: 10.1158/1535-7163.Targ-11-C129  0.311
2011 Tian J, Zhao H, Nolley R, Reese S, Young S, Li X, Peehl D, Knox S. Abstract B207: Darinaparsin is an anti-solid tumor cytotoxin in vivo. Molecular Cancer Therapeutics. 10. DOI: 10.1158/1535-7163.Targ-11-B207  0.347
2010 Brannon AR, Reddy A, Seiler M, Arreola A, Moore DT, Pruthi RS, Wallen EM, Nielsen ME, Liu H, Nathanson KL, Ljungberg B, Zhao H, Brooks JD, Ganesan S, Bhanot G, et al. Molecular Stratification of Clear Cell Renal Cell Carcinoma by Consensus Clustering Reveals Distinct Subtypes and Survival Patterns. Genes & Cancer. 1: 152-163. PMID 20871783 DOI: 10.1177/1947601909359929  0.309
2010 Zhao H, Nolley R, Chen Z, Peehl DM. Tissue slice grafts: an in vivo model of human prostate androgen signaling. The American Journal of Pathology. 177: 229-39. PMID 20472887 DOI: 10.2353/Ajpath.2010.090821  0.356
2010 Flamand V, Zhao H, Peehl DM. Targeting monoamine oxidase A in advanced prostate cancer. Journal of Cancer Research and Clinical Oncology. 136: 1761-71. PMID 20204405 DOI: 10.1007/S00432-010-0835-6  0.345
2010 Brannon AR, Reddy A, Seiler M, Arreola A, Chen S, Moore DT, Pruthi RS, Wallen EM, Nielsen ME, Liu H, Ljungberg B, Zhao H, Brooks JD, Ganesan S, Bhanot G, et al. Abstract 1996: Molecular stratification of clear cell renal cell carcinoma by consensus clustering reveals distinct subtypes and survival patterns Cancer Research. 70: 1996-1996. DOI: 10.1158/1538-7445.Am10-1996  0.333
2009 Zhao H, Flamand V, Peehl DM. Anti-oncogenic and pro-differentiation effects of clorgyline, a monoamine oxidase A inhibitor, on high grade prostate cancer cells. Bmc Medical Genomics. 2: 55. PMID 19691856 DOI: 10.1186/1755-8794-2-55  0.332
2009 Zhao H, Zongming Ma, Tibshirani R, Higgins JP, Ljungberg B, Brooks JD. Alteration of gene expression signatures of cortical differentiation and wound response in lethal clear cell renal cell carcinomas. Plos One. 4: e6039. PMID 19557179 DOI: 10.1371/Journal.Pone.0006039  0.302
2009 Zhao H, Peehl DM. Tumor-promoting phenotype of CD90hi prostate cancer-associated fibroblasts. The Prostate. 69: 991-1000. PMID 19267366 DOI: 10.1002/Pros.20946  0.361
2008 Peehl DM, Coram M, Khine H, Reese S, Nolley R, Zhao H. The significance of monoamine oxidase-A expression in high grade prostate cancer. The Journal of Urology. 180: 2206-11. PMID 18804811 DOI: 10.1016/J.Juro.2008.07.019  0.34
2008 Zhao H, Nolley R, Chen Z, Reese SW, Peehl DM. Inhibition of monoamine oxidase A promotes secretory differentiation in basal prostatic epithelial cells. Differentiation; Research in Biological Diversity. 76: 820-30. PMID 18248494 DOI: 10.1111/J.1432-0436.2007.00263.X  0.359
2007 Li TH, Zhao H, Peng Y, Beliakoff J, Brooks JD, Sun Z. A promoting role of androgen receptor in androgen-sensitive and -insensitive prostate cancer cells. Nucleic Acids Research. 35: 2767-76. PMID 17426117 DOI: 10.1093/Nar/Gkm198  0.327
2007 Zhao H, Brooks JD. Selenomethionine induced transcriptional programs in human prostate cancer cells. The Journal of Urology. 177: 743-50. PMID 17222674 DOI: 10.1016/J.Juro.2006.09.071  0.344
2007 Zhao H, Ramos CF, Brooks JD, Peehl DM. Distinctive gene expression of prostatic stromal cells cultured from diseased versus normal tissues. Journal of Cellular Physiology. 210: 111-21. PMID 17044071 DOI: 10.1002/Jcp.20828  0.338
2006 Zhao H, Ljungberg B, Grankvist K, Rasmuson T, Tibshirani R, Brooks JD. Gene expression profiling predicts survival in conventional renal cell carcinoma. Plos Medicine. 3: e13. PMID 16318415 DOI: 10.1371/Journal.Pmed.0030013  0.301
2005 Gu Z, Rubin MA, Yang Y, Deprimo SE, Zhao H, Horvath S, Brooks JD, Loda M, Reiter RE. Reg IV: a promising marker of hormone refractory metastatic prostate cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 2237-43. PMID 15788672 DOI: 10.1158/1078-0432.Ccr-04-0356  0.344
2005 Zhao H, Kim Y, Wang P, Lapointe J, Tibshirani R, Pollack JR, Brooks JD. Genome-wide characterization of gene expression variations and DNA copy number changes in prostate cancer cell lines. The Prostate. 63: 187-97. PMID 15486987 DOI: 10.1002/Pros.20158  0.333
2005 Zhao H, Lai F, Nonn L, Brooks JD, Peehl DM. Molecular targets of doxazosin in human prostatic stromal cells. The Prostate. 62: 400-10. PMID 15378519 DOI: 10.1002/Pros.20161  0.345
2004 Zhao H, Langerød A, Ji Y, Nowels KW, Nesland JM, Tibshirani R, Bukholm IK, Kåresen R, Botstein D, Børresen-Dale AL, Jeffrey SS. Different gene expression patterns in invasive lobular and ductal carcinomas of the breast. Molecular Biology of the Cell. 15: 2523-36. PMID 15034139 DOI: 10.1091/Mbc.E03-11-0786  0.314
2004 Zhao H, Whitfield ML, Xu T, Botstein D, Brooks JD. Diverse effects of methylseleninic acid on the transcriptional program of human prostate cancer cells. Molecular Biology of the Cell. 15: 506-19. PMID 14617803 DOI: 10.1091/Mbc.E03-07-0501  0.354
2001 Zhao H, Nonet ML. A conserved mechanism of synaptogyrin localization. Molecular Biology of the Cell. 12: 2275-89. PMID 11514616 DOI: 10.1091/Mbc.12.8.2275  0.606
2000 Zhao H, Nonet ML. A retrograde signal is involved in activity-dependent remodeling at a C. elegans neuromuscular junction. Development (Cambridge, England). 127: 1253-66. PMID 10683178  0.602
1998 Nonet ML, Saifee O, Zhao H, Rand JB, Wei L. Synaptic transmission deficits in Caenorhabditis elegans synaptobrevin mutants. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 18: 70-80. PMID 9412487 DOI: 10.1523/Jneurosci.18-01-00070.1998  0.614
Show low-probability matches.